Non-contact helium-based plasma for delivery of DNA vaccines

References

• Liu MA. DNA vaccines: an historical perspective and view to the future. Immunol Rev 2011; 239:62 - 84; http://dx.doi.org/10.1111/j.1600-065X.2010.00980.x; PMID: 21198665
   PubMed Web of Science ®Google Scholar
• Morrow MP, Weiner DB. DNA drugs come of age. Sci Am 2010; 303:48 - 53; http://dx.doi.org/10.1038/scientificamerican0710-48; PMID: 20583666
   PubMed Web of Science ®Google Scholar
• Manoj S, Babiuk LA, van Drunen Littel-van den Hurk S. Approaches to enhance the efficacy of DNA vaccines. Crit Rev Clin Lab Sci 2004; 41:1 - 39; http://dx.doi.org/10.1080/10408360490269251; PMID: 15077722
   PubMed Web of Science ®Google Scholar
• Morrow MP, Yan J, Pankhong P, Ferraro B, Lewis MG, Khan AS, et al. Unique Th1/Th2 phenotypes induced during priming and memory phases by use of interleukin-12 (IL-12) or IL-28B vaccine adjuvants in rhesus macaques. Clin Vaccine Immunol 2010; 17:1493 - 9; http://dx.doi.org/10.1128/CVI.00181-10; PMID: 20685940
   PubMed Web of Science ®Google Scholar
• Rice J, Ottensmeier CH, Stevenson FK. DNA vaccines: precision tools for activating effective immunity against cancer. Nat Rev Cancer 2008; 8:108 - 20; http://dx.doi.org/10.1038/nrc2326; PMID: 18219306
   PubMed Web of Science ®Google Scholar
• Kim JJ, Ayyavoo V, Bagarazzi ML, Chattergoon MA, Dang K, Wang B, et al. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J Immunol 1997; 158:816 - 26; PMID: 8992999
   PubMed Web of Science ®Google Scholar
• Sardesai NY, Weiner DB. Electroporation delivery of DNA vaccines: prospects for success. Curr Opin Immunol 2011; 23:421 - 9; http://dx.doi.org/10.1016/j.coi.2011.03.008; PMID: 21530212
   PubMed Web of Science ®Google Scholar
• Heller LC, Ugen K, Heller R. Electroporation for targeted gene transfer. Expert Opin Drug Deliv 2005; 2:255 - 68; http://dx.doi.org/10.1517/17425247.2.2.255; PMID: 16296752
   PubMedGoogle Scholar
• Broderick KE, Shen X, Soderholm J, Lin F, McCoy J, Khan AS, et al. Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device. Gene Ther 2011; 18:258 - 65; http://dx.doi.org/10.1038/gt.2010.137; PMID: 20962869
   PubMed Web of Science ®Google Scholar
• Donate A, Coppola D, Cruz Y, Heller R. Evaluation of a novel non-penetrating electrode for use in DNA vaccination. PLoS One 2011; 6:e19181; http://dx.doi.org/10.1371/journal.pone.0019181; PMID: 21559474
   PubMed Web of Science ®Google Scholar
• Daud AI, DeConti RC, Andrews S, Urbas P, Riker AI, Sondak VK, et al. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol 2008; 26:5896 - 903; PMID: 19029422
   PubMed Web of Science ®Google Scholar
• Denet AR, Vanbever R, Préat V. Skin electroporation for transdermal and topical delivery. Adv Drug Deliv Rev 2004; 56:659 - 74; http://dx.doi.org/10.1016/j.addr.2003.10.027; PMID: 15019751
   PubMed Web of Science ®Google Scholar
• Prausnitz MR. The effects of electric current applied to skin: A review for transdermal drug delivery. Adv Drug Deliv Rev 1996; 18:395 - 425; http://dx.doi.org/10.1016/0169-409X(95)00081-H
   Web of Science ®Google Scholar
• Connolly RJ, Lopez GA, Hoff AM, Jaroszeski MJ. Plasma facilitated delivery of DNA to skin. Biotechnol Bioeng 2009; 104:1034 - 40; http://dx.doi.org/10.1002/bit.22451; PMID: 19557830
   PubMed Web of Science ®Google Scholar
• Connolly RJ, Lopez GA, Hoff AM, Jaroszeski MJ. Characterization of plasma mediated molecular delivery to cells in vitro. Int J Pharm 2010; 389:53 - 7; http://dx.doi.org/10.1016/j.ijpharm.2010.01.016; PMID: 20083175
   PubMed Web of Science ®Google Scholar
• Ogawa Y, Morikawa N, Ohkubo-Suzuki A, Miyoshi S, Arakawa H, Kita Y, et al. An epoch-making application of discharge plasma phenomenon to gene-transfer. Biotechnol Bioeng 2005; 92:865 - 70; http://dx.doi.org/10.1002/bit.20659; PMID: 16170826
   PubMed Web of Science ®Google Scholar
• Ramachandran N, Jaroszeski MJ, Hoff AM. Molecular delivery to cells facilitated by corona ion deposition. IEEE Trans Nanobioscience 2008; 7:233 - 9; http://dx.doi.org/10.1109/TNB.2008.2002290; PMID: 18779104
   PubMed Web of Science ®Google Scholar
• Broderick KE, Kardos T, McCoy JR, Fons MP, Kemmerrer S, Sardesai NY. Piezoelectric permeabilization of mammalian dermal tissue for in vivo DNA delivery leads to enhanced protein expression and increased immunogenicity. Hum Vaccin 2011; 7:Suppl 22 - 8; http://dx.doi.org/10.4161/hv.7.0.14559; PMID: 21263230
   PubMed Web of Science ®Google Scholar
• Connolly RJ, Rey JI, Lambert VM, Wegerif G, Jaroszeski MJ, Ugen KE. Enhancement of antigen specific humoral immune responses after delivery of a DNA plasmid based vaccine through a contact-independent helium plasma. Vaccine 2011; 29:6781 - 4; http://dx.doi.org/10.1016/j.vaccine.2010.12.054; PMID: 21195804
   PubMed Web of Science ®Google Scholar
• Kohler JJ, Tuttle DL, Coberley CR, Sleasman JW, Goodenow MM. Human immunodeficiency virus type 1 (HIV-1) induces activation of multiple STATs in CD4+ cells of lymphocyte or monocyte/macrophage lineages. J Leukoc Biol 2003; 73:407 - 16; http://dx.doi.org/10.1189/jlb.0702358; PMID: 12629155
   PubMed Web of Science ®Google Scholar
• Streeck H, Frahm N, Walker BD. The role of IFN-gamma Elispot assay in HIV vaccine research. Nat Protoc 2009; 4:461 - 9; http://dx.doi.org/10.1038/nprot.2009.7; PMID: 19282851
   PubMed Web of Science ®Google Scholar
• Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1982; 1:841 - 5; PMID: 6329708
   PubMed Web of Science ®Google Scholar
• Weaver JC. Electroporation theory. Concepts and mechanisms. Methods Mol Biol 1995; 48:3 - 28; PMID: 8528402
   PubMedGoogle Scholar
• Draghia-Akli R, Khan AS, Brown PA, Pope MA, Wu L, Hirao L, et al. Parameters for DNA vaccination using adaptive constant-current electroporation in mouse and pig models. Vaccine 2008; 26:5230 - 7; http://dx.doi.org/10.1016/j.vaccine.2008.03.071; PMID: 18450333
   PubMed Web of Science ®Google Scholar
• Ferraro B, Cisper NJ, Talbott KT, Philipson-Weiner L, Lucke CE, Khan AS, et al. Co-delivery of PSA and PSMA DNA vaccines with electroporation induces potent immune responses. Hum Vaccin 2011; 7:Suppl 120 - 7; http://dx.doi.org/10.4161/hv.7.0.14574; PMID: 21266849
   PubMed Web of Science ®Google Scholar
• Heller R, Shirley S, Guo S, Donate A, Heller L. Electroporation based gene therapy — From the bench to the bedside. Engineering in Medicine and Biology Society,EMBC, 2011 Annual International Conference of the IEEE, 2011:736-8.
   Google Scholar
• Kraynyak KA, Kutzler MA, Cisper NJ, Khan AS, Draghia-Akli R, Sardesal NY, et al. Systemic immunization with CCL27/CTACK modulates immune responses at mucosal sites in mice and macaques. Vaccine 2010; 28:1942 - 51; http://dx.doi.org/10.1016/j.vaccine.2009.10.095; PMID: 20188250
   PubMed Web of Science ®Google Scholar
• Lin F, Shen X, McCoy JR, Mendoza JM, Yan J, Kemmerrer SV, et al. A novel prototype device for electroporation-enhanced DNA vaccine delivery simultaneously to both skin and muscle. Vaccine 2011; 29:6771 - 80; http://dx.doi.org/10.1016/j.vaccine.2010.12.057; PMID: 21199706
   PubMed Web of Science ®Google Scholar
• Mallilankaraman K, Shedlock DJ, Bao H, Kawalekar OU, Fagone P, Ramanathan AA, et al. A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates. PLoS Negl Trop Dis 2011; 5:e928; http://dx.doi.org/10.1371/journal.pntd.0000928; PMID: 21264351
   PubMed Web of Science ®Google Scholar
• Kutzler MA, Kraynyak KA, Nagle SJ, Parkinson RM, Zharikova D, Chattergoon M, et al. Plasmids encoding the mucosal chemokines CCL27 and CCL28 are effective adjuvants in eliciting antigen-specific immunity in vivo. Gene Ther 2010; 17:72 - 82; http://dx.doi.org/10.1038/gt.2009.112; PMID: 19847203
   PubMed Web of Science ®Google Scholar